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Identification of a Developmental Gene Expression
Signature, Including HOX Genes,
for the Normal Human Colonic Crypt Stem Cell Niche:
Overexpression of the Signature Parallels Stem Cell
Overpopulation During Colon Tumorigenesis
Seema Bhatlekar,1,* Sankar Addya,2,* Moreh Salunek,2 Christopher R. Orr,2 Saul Surrey,2
Steven McKenzie,2 Jeremy Z. Fields,3 and Bruce M. Boman1,2
Our goal was to identify a unique gene expression signature for human colonic stem cells (SCs). Accordingly, we
determined the gene expression pattern for a known SC-enriched region—the crypt bottom. Colonic crypts and
isolated crypt subsections (top, middle, and bottom) were purified from fresh, normal, human, surgical speci-
mens. We then used an innovative strategy that used two-color microarrays (*18,500 genes) to compare gene
expression in the crypt bottom with expression in the other crypt subsections (middle or top). Array results were
validated by PCR and immunostaining. About 25% of genes analyzed were expressed in crypts: 88 preferentially
in the bottom, 68 in the middle, and 131 in the top. Among genes upregulated in the bottom, *30%
were classified as growth and/or developmental genes including several in the PI3 kinase pathway, a six-
transmembrane protein STAMP1, and two homeobox (HOXA4, HOXD10) genes. qPCR and immunostaining
validated that HOXA4 and HOXD10 are selectively expressed in the normal crypt bottom and are overexpressed
in colon carcinomas (CRCs). Immunostaining showed that HOXA4 and HOXD10 are co-expressed with the SC
markers CD166 and ALDH1 in cells at the normal crypt bottom, and the number of these co-expressing cells is
increased in CRCs. Thus, our findings show that these two HOX genes are selectively expressed in colonic SCs
and that HOX overexpression in CRCs parallels the SC overpopulation that occurs during CRC development.
Our study suggests that developmental genes play key roles in the maintenance of normal SCs and crypt
renewal, and contribute to the SC overpopulation that drives colon tumorigenesis.
Introduction
Identifying, isolating, and characterizing human colonicstem cells (SCs) has been challenging. First, there are a
limited number of markers [1] that can unambiguously
identify human gastrointestinal (GI) SCs, in large part because
they are undifferentiated relative to other crypt cells, and lack
typical tissue-specific differentiation markers. Second, human
colonic SCs appear to be few in number, accounting for < 5%
of all crypt cells. Third, to purify them, human colonic SCs
need to be isolated from their stromal support. Indeed, much
of the research to date on human colonic SCs primarily has
relied on anatomical and functional properties of SCs, in-
cluding location at the crypt base, strong anchorage, extended
proliferative potential over time, capacity for self renewal,
and multipotency [2].
Accordingly, we devised an innovative strategy for the
identification of human colonic SCs. Since colonic SCs
have unique functional properties, the lower crypt, which
contains most colonic SCs, should have a unique gene
expression profile that should be discernable by micro-
array analysis. Therefore, in the current study, we (1)
isolated pure crypts from surrounding stromal ele-
ments [3], (2) isolated crypt subsections (bottom, middle,
and top), and then (3) used microarray-based gene
expression profiling to compare the crypt bottom, a SC-
enriched region, with the other crypt subsections (middle
and top).
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Identifying and characterizing colonic SCs also has clinical
relevance because mutation-induced dysregulation of co-
lonic SC dynamics is likely to contribute to the initiation and
progression of colorectal cancer (CRC). Indeed, we showed
[1] that APC mutations initiate and drive colon tumorigen-
esis by causing progressive colonic SC overpopulation.
Materials and Methods
Acquisition of tissue
We used freshly isolated colonic crypts from surgical
specimens because we needed to obtain relatively large
amounts of purified crypt subsections—bottom, middle, and
top—that were free of contaminating stromal tissues such as
fibroblasts, leukocytes, endothelial cells, and muscle cells.
Specimens of fresh normal colonic epithelium were obtained
from colectomy specimens through the Thomas Jefferson
University Pathology Department. All tissues obtained and
protocols used were done with the approval of the Institu-
tional Review Board. Tissue samples (n = 3) representing
normal colon were taken from the distal margin of resection
of tumors of surgical colectomy specimens (> 10 cm away
from the tumor) from colon cancer or colon adenoma pa-
tients who were otherwise healthy and who had no known
clinical risk factors for hereditary colon cancer (ie, no other
family members with CRC and none diagnosed under age
60). Normal-appearing, APC-mutant colon was obtained
from prophylactic colectomy specimens from two familial
adenomatous polyposis (FAP) patients with known germline
APC mutations—one of whom was being treated with the
chemopreventive agent Sulindac.
Isolation of whole colonic crypts
and crypt subsections
Crypt subsections (top, middle, and bottom) were purified
from tissue samples according to modification of a method
that we developed [3] for isolation of whole human colonic
crypts. Briefly, the mucosal layer was surgically dissected
from underlying submucosal layers of the colon, placed in
sterile phosphate-buffered saline (PBS), and washed 3 · . The
specimen was incubated in 0.04% Na hypochlorite for 15 min
at room temp. To isolate crypt top subsections, each speci-
men was transferred to a PBS solution containing 0.05 mM
EDTA, pH 8.0, incubated for 45 min at room temperature,
and vigorously shaken by hand for 5 min. The supernatant
was removed, the tissue washed thrice with sterile PBS, and
the crypt top subsections that had been dislodged into so-
lution were precipitated by centrifugation at 500 g at 4C. To
isolate crypt middle subsections, the same specimen was
then transferred to media containing 0.5 mM EDTA in PBS
and re-incubated for 30–60 min, and again the tube was
shaken by hand for 5 min. The crypt middle subsections that
were dislodged were precipitated as above. To isolate crypt
bottom subsections the same specimen was then incubated in
media containing 3 mM EDTA in PBS and re-incubated fol-
lowed by shaking. Crypt bottom subsections were isolated
and precipitated as above. Crypt subsection quality was
checked by inverted phase microscopy (Supplementary
Fig. S1; Supplementary Data are available online at www
.liebertpub.com/scd).
Two-color arrays
Two-color microarray profiling was used to characterize
gene expression patterns in colonocytes from the three crypt
subsections. Our primary objective was to compare the pat-
tern of gene expression for cells at the crypt base with the
patterns in the two other crypt regions to begin to determine
which genes are preferentially expressed at the crypt base,
the crypt subregion where SC reside. This involved isolating
RNA from purified colonic crypt subsections that were ob-
tained as described above and then doing microarray pro-
filing for each crypt subsection.
Array-based mRNA expression profiling consisted of
several steps: (1) preparation of labeled RNA targets, (2)
preparation of the microarray, (3) hybridization and post-
hybridization stringency washes, (4) detection and data ac-
quisition of signal intensities, and (5) comparative data
analysis and visualization. Note that according to standard
array nomenclature the probes are bound to the array while
the radio-labeled or dye-tagged target is in the solution.
Preparation of labeled RNA targets
This experiment was repeated twice. Isolated RNA was
annealed to magnetic Dyna beads Oligo (dT)25 (Dynal Bio-
tech, Lake Success, NY) on which first strand synthesis was
initiated with reverse transcriptase. In brief, 20mg of total
RNA in 75 mL DEPC-treated water was heated at 65C for
2 min to disrupt the secondary structures and was placed on
ice. Then, 150 mL (750 mg) Dynabeads Oligo (dT)25 were ad-
ded to a 1.5 mL Eppendorf tube and the vial was placed on
the Dynal MPC-S support. After 30 s, the supernatant was
discarded, and the beads were washed with 150 mL 2·
Binding Buffer and resuspended in 75 mL of 2· Binding
buffer. Total RNA was added to the Dynabeads Oligo (dT)25
in Binding Buffer, mixed thoroughly, and annealed for 5 min
at room temperature. The tube was kept on the magnet for at
least 30 s and the supernatant was discarded. The beads in
the tube were washed twice using 200mL of washing buffer.
Bead-bound RNA was reverse transcribed to bead-bound
cDNA with SuperScript II reverse transcriptase according to
the manufacturer’s protocol (Invitrogen, Carlsbad, CA).
After 1 h, the beads were captured, the supernatant dis-
carded, and the beads heated at 95C in the presence of 2 mM
EDTA. Random Prime Labeling (Invitrogen) was used to
generate a radio-labeled target complementary to bead-
bound cDNA with 2mL Cy5/Cy3 dCTP (Amersham Bios-
ciences, Sunnyvale, CA) for glass microarray slides.
Hybridization and post-hybridization stringency
washes
Two-color microarray profiling was then used to charac-
terize differential gene expression in crypt subsections. The
18,432 human cDNA clones in the gene set were grown
overnight in 384-well microtiter plates. The inserts were PCR
amplified using vector-specific primers M13F and M13R.
PCR products were precipitated by ethanol, resuspended in
50% (v/v) DMSO, and printed on Poly-L-Lysine-treated
glass slides as two separate arrays, one on each of two glass
slides, and are referred to herein as data sets 1 and 2. The
slides were then prepared for hybridization by blocking with
succinic anhydride. Column purified Cy-3/Cy-5-labeled
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targets were dried and resuspended in 30mL hybridization
solution [20 mg denatured Cot1 DNA, 20 mg poly-d(A), 4·
SSC, and 0.2% (w/v) SDS]. The hybridization solution was
added to the microarray slide, covered with a glass coverslip,
and hybridized at 65C for 16–18 h in a humid environment to
prevent drying. The coverslip was gently removed in solution
(40 mL 2 · SSC, 0.1% SDS) and the slide was then rinsed se-
quentially at room temperature with 40 mL 2 · SSC, 0.1%
SDS, 1· SSC, and finally 0.1 · SSC, for 4 min each rinse.
Slides were centrifuged at 500 rpm for 5 min to dry them.
Data acquisition and analysis
Microarray slides were scanned and the fluorescence in-
tensity of each spot recorded using a ScanArray 5000 (Perkin
Elmer, Boston MA), dual-color confocal laser scanner. Ex-
pression data were determined from paired (Cy5 and Cy3)
16-bit TIFF images using Quantarray. Specifically, the Cy5
and Cy3 images were used to quantify spot intensity fol-
lowing the adaptive method in the Quantarray 3.0 software
(Perkin Elmer) to generate raw data files containing mea-
surements of signal and background intensity. Background
values based on signal intensities around each spot were
subtracted and results were then normalized for differences
in dye signal intensity using the Loess principle. Based on
visual inspection of the scatterplots (Supplementary Fig. S2),
all data below an intensity of 800 counts were considered
insufficiently greater than background and were discarded
(about 75% of genes). Each array contained duplicate spots
for each gene. Therefore, all four spots were analyzed to
assess replication. Data where all four spots did not possess
an intensity within three standard deviations of each other,
or did not show an up- or downregulation of 1.5-fold or
greater, were discarded. This left a maximum of 2.13% of the
data (415 genes) for consideration. For retained data, the
mean intensity for each gene was quantified using all four
spots. All further analysis was performed using the final
gene list with these mean intensity values. Determination of
the genes that showed differential expression was based on
increased or decreased signal intensity of 1.5-fold or more
between the two channels (Cy5 vs. Cy3). Graphic and in-
formatic analyses of the data were performed using Gene-
Spring Software Version 6.1 (Silicon Genetics, Redwood City,
CA). Gene ontology, annotation, and pathway analysis was
performed using OntoGene (http://vortex.cs.wayne.edu:
8080/ontoexpress/servlet/UserInfo) and EASE (www
.david.niaid.nih.gov/david/ease1.htm).
Immunofluorescence staining of paraffin-embedded
sections
Immunofluorescence studies were carried out (after IRB
approval) on 5mm paraffin sections of human colonic tissues
from archival tissue blocks from Christiana Care Health
System. The slides were deparaffinized in citra solv solution
for 20 min to remove the embedding media, and washed
twice in absolute ethanol for 5 min each. The slides were then
gradually rehydrated gently in a series of 95% alcohol wa-
shes for 5 min each and were placed in distilled water for few
seconds. Antigen retrieval was performed for tissue sections
in 1 · retrieval solution (Dako) for 25 s, at full power in a
microwave and then for 12 min at low power. Slides were
allowed to cool to room temperature and were rinsed in 1 · -
TBS buffer thrice for 5 min each. The slides were then incu-
bated overnight in 1· -TBS buffer containing 10% normal
goat serum and 3% bovine serum albumin (BSA) to block
nonspecific antibody binding. This was followed by incu-
bation of the slides with primary antibody (4C, overnight),
diluted 1:100 except for anti-STAMP, which was at 1:200. The
primary antibodies used were anti-HOXA4 (Abcam 26097)
and HOXD10 (Abcam 76897). Anti-ALDH (BD 611195), anti-
CD166 (Abcam 49496), and anti-STAMP1 (Novus 68100)
antibodies were the primary antibodies used in co-staining
experiments. Next day, slides were washed thrice in 1X-TBS
buffer for 5 min each. Tissues were then stained with anti-
rabbit Alexa-fluor antibody (Invitrogen) (diluted at 1:1,000)
and Hoechst 33342 (1:10,000) for 60 min. After final washes,
slides were mounted with a coverslip using slow fade gold
antifade reagent (Invitrogen S36936) and were sealed with
clear nail polish.
Whole isolated colonic crypts were stained using anti-
HOXA4 (Abcam 26097) and HOXD10 (Abcam 76897). Iso-
lated colonic crypts were incubated in 0.2% Triton X-100 in
1· PBS for 5 min, followed by washing with 1· PBS.
Blocking was performed using 3% BSA and 10% goat serum
for 1 h at room temperature. After blocking, crypts were
washed with 1· PBS. Primary antibody incubation was
done for 1 h at room temperature. After washing crypts with
1· PBS, crypts were stained with anti-rabbit Alexa-fluor
antibody (Invitrogen) (diluted at 1:1,000) and Hoechst 33342
(1:10,000) for 60 min. Stained crypts were then observed
under a flouroscence microscope.
Real-time quantitative RT-PCR analysis
Total RNA from normal colonic crypts and colon tumor
tissues were isolated using the TRIzol method. Equal amounts
of RNA from both samples were reverse transcribed and
amplified in a one-step reaction using Superscript III reverse
transcriptase (Invitrogen 18080-44). Real-time PCR was per-
formed using SYBR green PCR master mix (4309155 Applied
Biosystem). Human HOXA4 and HOXD10 were amplified
with gene-specific primers (HOXA4 sense primer: 5¢-
TCCCCATCTGGACCATAATAGG-3¢; antisense primer: 5¢-
GCAACCAGCACAGACTCTTAACC-3¢ and HOXD10 sense
5¢-ATAAGCGCAACAAACTCATTTCG-3¢ and anti- sense
5¢-ATATCGAGGGACGGGAACCT-3¢. b-actin (ACTB) was
amplified as an internal control by using gene-specific prim-
ers, sense primer: 5¢-TTGCCGACAGGATGCAGAA-3¢; anti-
sense primer: 5¢-GCCGATCCACACGGAGTACT-3¢. Cycling
parameters used were denaturation at 95C for 10 min, 40
cycles of 15 s at 94C, 30 s at 60C, 1 min at 72C followed by a
continuous melting curve. For real-time PCR validation, anal-
ysis was done using documented SC markers including ALD-
H1A1, LGR5, CD166 (ALCAM),DCLK1, and CD133 (PROM1).
Human ALDH1a primers used were forward 5¢-GTTGTC
AAACCAGCAGAGCA-3¢ and human ALDH1A reverse 5¢-
CTGTAGGCCCATAACCAGGA-3¢. Lgr5 human primers
used were forward 5¢-CTTCCAACCTCAGCGTCTTC-3¢ and
reverse 5¢-TTTCCCGCAAGACGTAACTC-3¢. Human CD166
(ALCAM) primers were forward 5¢-TAGCAGGAATGCAA
CTGTGG-3¢ and reverse 5¢-CGCAGACATAGTTTCCAGCA-
3¢. Human DCLK1 primers used were forward 5¢-TGAA
CAAGAAGACGGCTCACTCC-3¢ and reverse 5¢-GCTGG
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TGGGTGATGGACTTGG-3¢. Human CD133 (PROM1) prim-
ers used were 5¢-GGACCCATTGGCATTCTC-3¢ and reverse
5¢-CAGGACACAGCATAGAATAATC-3¢.
In this case, b-actin (ACTB) was the internal control, using
sense primer 5¢-CCCAGCACAATGAAGATCAA-3¢ and 5¢-
ACATCTGCTGGAAGGTGGAC-3¢ as antisense primer. Cy-
cling parameters used for ALDH1A1, CD166 (ALCAM), and
LGR5 were denaturation at 95C for 10 min, 40 cycles of 15 s at
95C, 60 s at 60C. Cycling parameters used for CD133
(PROM1) were 50C for 2 min, 95C for 10 min, 40 cycles of
15 s at 95C, 1 min at 60C. Cycling parameters for DCLK1
were denaturation at 95C for 10 min, followed by 35 cycles of
15 s at 95C, 30 s at 65C, 30 s at 72C then 72C for 10 min. The
Ct value was then normalized to the internal housekeeping
gene b-actin (ACTB). Fold change was determined for tumor
samples compared to normal samples. This was calculated
by the formula fold change = 2^Avg.(Delta(Ct))Tumor/
2^Avg.(Delta(Ct))Normal
Statistical analysis
Student’s t-test was performed on real-time PCR data and
P < 0.05 was considered significant.
Results
Microarray analysis
RNA samples from crypt subsections (Supplementary Fig.
S1) showed hybridization to *4,000 of the *18,500 genes
analyzed (ie, to *22% of the clones on the array). An average
correlation from a self-hybridization consistently yielded a
value of *0.96 (Supplementary Fig. S2A). Each array was
normalized using the Loess method [4,5]. This method cen-
tered the data around onefold expression ratios, and back-
ground cutoffs were calculated using transformed data (to
log base 2) (Supplementary Fig. S2B). The experiment was set
up as a loop design; therefore, normalization was performed
between arrays using the samples. Raw intensity values
ranged from 800 counts to 45,000 counts, showing that the
experiment utilized the full dynamic range of the scanner. As
expected, *95% of all genes showed no difference in ex-
pression between crypt subsections and no significant out-
liers or dye bias was detected. Using the log plot
(Supplementary Fig. S2C) to determine the background
cutoff, any value under 800 counts was not considered.
Bioinformatic analysis
After normalization, data from any probe where all four
values were not within 2 standard deviations of each other
were not further considered. Data for probes that showed
less than a 1.5-fold change were also not used. This left 2.13%
of the original gene set to consider. Analysis of overlap was
then used to determine which of these genes were up- or
downregulated in each of the crypt subsections relative to
the other two subsections. This is shown in Venn diagrams
(Fig. 1A, B). In this analysis, we recognized that many genes
are known to be expressed in a gradient fashion along the
crypt axis. To determine which genes are preferentially ex-
pressed in the different crypt subsections, rather than in a
gradient fashion, we made several comparisons. For exam-
ple, there were 128 genes upregulated in the bottom relative
to the middle (Fig. 1B). Forty of the 128 were also upregu-
lated (but usually less so) in the middle relative to the top.
This indicates that these 40 genes are expressed in a gradient
fashion along the crypt axis, and that 88 genes are prefer-
entially expressed in the bottom. Similarly, of the 96 genes
upregulated in the middle relative to the top or the bottom
(Fig. 1B), there were 28 that were upregulated in the bottom
relative to the top or vice versa. Thus, we classified 68 genes
(96 - 28= 68) as being preferentially expressed in the middle.
Using this approach, we found that 287 mRNA species were
preferentially expressed in one of the three different crypt
FIG. 1. Identification of un-
ique upregulated gene ex-
pression signatures for each
crypt section by Venn analy-
sis. (A) Comparisons were
made between gene expres-
sion data for each crypt sub-
section. (B) Results from Venn
analysis. The top Venn dia-
gram shows that there is no
crossover; none of the same
genes were upregulated in
both top and bottom. The
bottom Venn diagram shows
that a considerable number of
genes are upregulated in the
middle compared with both
bottom and top.
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subsections: 88 in the crypt bottom; 68 in the crypt middle;
131 in the crypt top. Some (39%) of these transcripts are
known genes (Supplementary Table S1), but many (61%) are
expressed sequence tags and are as yet unidentified.
We then performed cluster analysis (Supplementary Fig.
S3) as an exploratory visual approach. We analyzed the gene
set from array 1 and called that dataset 1 (Supplementary
Figs. S3A, S3C), and from array 2 and called that dataset 2
(Supplementary Figs. S3B, S3D). Both were randomly chosen
gene sets from 10 different human tissues. K-means cluster
analysis was performed on each of these data sets. No un-
ique cellular pathway was apparent from this analysis. But,
we did find that each dataset could be partitioned into the
same four clusters (Supplementary Fig. S3C, S3D). Hier-
archical clustering was performed on the three gene lists
from the three crypt subsections, subgrouped, as noted
above, into datasets 1 (Fig. 2A) and 2 (Fig. 2B). The data
clearly showed that there is a gene expression signature in
the crypt bottom that is unique relative to the middle and
top. In dataset 1, many genes that are up in the bottom
versus the top show relatively little change in the middle
versus the top. In dataset 2, there are also many genes up in
the bottom versus the top that are also up in the middle
versus the top. These latter genes appear to be expressed as a
gradient: highest in the bottom and decreasing toward the
top of the crypt. In contrast, genes that are up in the bottom
versus the top, but not up in the middle versus the top,
appear to be selectively expressed in the bottom.
Gene ontology was performed on all three gene lists
(bottom, middle, and top) collectively to identify common
themes, patterns, and/or molecular functions. Of these
genes, 30% had a known function. The majority of the genes
were involved in binding. Forty percent were genes whose
functions were involved in protein binding. Several genes
that are known to play a role in SC dynamics and/or de-
velopment were identified (Supplementary Fig. S4), which is
consistent with the fact that the crypt bottom is enriched in
SCs. Indeed, among the genes upregulated in the crypt
bottom, *30% were classified as growth and/or develop-
mental genes. This includes two genes, HOXA4 and
HOXD10, which are known to be involved in development—
they were upregulated (more than twofold) in the crypt
bottom. Also, there were several interesting cancer-related
genes. Six of them mapped to the PI3 kinase pathway
(Supplementary Fig. S5). Several also appeared to be part of
the MAP kinase pathway. The gene showing the greatest
upregulation (4.1-fold) in expression in the bottom relative to
the top was STAMP1 (also known as PCANAP1 or STEAP2),
which is a marker for prostate cancer.
Validation using real-time PCR and immunostaining
We performed real-time PCR analysis to validate our mi-
croarray analysis. We chose HOXA4, HOXD10, and
STAMP1 as our target genes and b-actin as our endogenous
control. Expression of five known SC markers ALDH1,
FIG. 2. Hierarchical cluster analysis of our microarray results for genes expressed in the crypt bottom (bottom vs. top). (A)Data set 1.
(B)Data set 2. (C)Color bar for expression ratios. This analysis shows that there are two sets of genes with increased expression (reddish
brown color) in the crypt bottom: genes selectively expressed in the bottom (A); genes that are expressed in a gradient fashion (B) from
highest in the crypt bottom to lowest in the crypt top. Color images available online at www.liebertpub.com/scd
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CD166, CD133, LGR5, and DCLK1 was used as a positive
control. Values were obtained for DDCt, comparing the crypt
subsections: bottom versus middle (Fig. 3). The real-time
PCR data were consistent with the microarray results:
HOXA4, HOXD10, and STAMP1 were each upregulated, as
were the positive controls (ALDH1, CD166, CD133, LGR5,
and DCLK1), in the bottom relative to the middle. As an
independent method of validation, we did immunostaining,
which confirmed that HOXD10 and HOXA4 are selectively
expressed in the bottom of the colonic crypt (Supplementary
Fig. S6 and Figs. 4 and 5). Co-staining studies using the SC
markers CD166 and ALDH1 were done to determine whe-
ther HOXD10 and HOXA4 are expressed in SCs. Results
showed that in normal colonic crypts, cells that stain for
HOXA4 and HOXD10 co-stain for CD166 and ALDH1 (Fig.
6). Co-staining studies were also done using HOXD10 and
STAMP1. Results showed that cells co-stain for HOXD10 and
STAMP1 in the bottom of the colonic crypt. Results also
showed an increased number of cells that co-stain for
HOXD10 and STAMP1 in colon carcinomas (CRCs) (Sup-
plementary Fig. S7).
Analysis of gene expression in FAP crypts
Given that cancer SCs have been widely implicated in
tumorigenesis in blood and several solid organs, we did a
preliminary, hypothesis-generating study of gene expression
changes in APC-mutant colon. In this pilot study, we ana-
lyzed gene expression in isolated whole FAP crypts and
compared results to whole crypts isolated from healthy
controls using a chip that contained 18,474 genes. These FAP
patients had germline APC mutations that predispose them
to develop CRC. For FAP, 6,159 genes were upregulated
more than twofold, and 1,291 genes were downregulated
more than twofold. We also isolated and analyzed crypts
from an FAP patient treated with a nonsteroidal anti-
inflammatory drug (NSAID), Sulindac, which is known to
inhibit and even reverse adenoma development. In this pa-
tient, of the 18,474 genes, 271 were upregulated more than
twofold; 421 were downregulated more than twofold com-
pared with crypts from an untreated FAP patient (Supple-
mentary Fig. S8). Thus, fewer than 4% of genes analyzed
changed in expression with Sulindac treatment. We also did
a survey of a subset of the genes (n = 47) from the gene set
that we had identified to be selectively expressed in the
bottom of normal crypts. Among this subset of genes, 18
were overexpressed (more than twofold) in whole crypts
from the untreated FAP patient compared with whole crypts
from healthy controls. For all 18 genes, the level of expres-
sion was not lowered by Sulindac in the treated FAP case.
Taken together, these data suggest that many genes selec-
tively expressed in the crypt bottom of healthy controls are
overexpressed in the SC niche of FAP crypts.
Expression of HOX genes in CRCs
Because colonic SC overpopulation occurs during colon
tumorigenesis [1], we analyzed the expression of HOXD10
and HOXA4 in carcinomas. Immunostaining revealed that
HOXD10 and HOXA4 expression in malignant colonic epi-
thelium is substantially increased (both the number of cells
staining and the intensity of the staining) in expression
compared with normal colonic epithelium (Figs. 4 and 5).
Quantitative PCR also showed that HOXA4 and HOXD10
are highly overexpressed in most CRCs (Fig. 7A). The SC
markers CD166 and ALDH1 co-stained with HOXA4 or
HOXD10 and there was more co-staining (both the number of
cells co-staining and the intensity of the co-staining) in CRCs
(Fig. 7B) compared with normal colonic epithelium (Fig. 6).
Discussion
Main findings
Because colonic SC have unique functional characteris-
tics—including lifetime proliferative capacity, capacity for
self-renewal, anchorage, and multipotency—these cells
should have a unique gene expression profile as should the
region in which they reside, the SC niche at the crypt base.
Our findings using microarray analysis demonstrate that
there is indeed a unique gene expression pattern for the
bottom 1/3 of human colonic crypts that distinguishes this
region from the crypt middle and top.
FIG. 3. Real-time PCR validation for
selective expression of HOXA4,
HOXD10, and STAMP1 in the crypt
bottom. Positive controls (known SC
markers) were LGR5, CD133, DCLK1,
ALDH1A1, and CD166, which are
known to be preferentially expressed
in the crypt bottom. Each bar repre-
sents a ratio of gene expression in
crypt bottom subsections divided by
that in crypt middle subsections. Error
bars represent SEM values. SC, stem
cell.
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Validity of our microarray methods
The use of an array representing a wide spectrum of genes is
the most appropriate approach for this type of experiment be-
cause it ensures that novel genes are not missed by focusing our
gene list too narrowly. Since we had little a priori knowledge
regarding what genes might be uniquely over- or under-
expressed in the crypt bottom, we used a robust normalization
approach to adjust for outliers. However, since the availability of
tissue was limited, and our sample (n=3) and replicate number
FIG. 4. HOXD10 expression in normal colon and carcinomas. Blue indicates nuclear staining with Hoechst dye; green indicates
HOXD10 expression. Upper panels: normal colon. Lower panels: malignant colon. Scale bar=20mm. Color images available online at
www.liebertpub.com/scd
FIG. 5. HOXA4 expression in normal colon and carcinomas. Blue indicates nuclear staining with Hoechst dye; green indicates
HOXA4 expression. Upper panels: normal colon. Lower panels: malignant colon. Scale bar=20mm. Color images available online at
www.liebertpub.com/scd
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(n=4) were thus relatively small, we used a very aggressive
method for eliminating false positives. Indeed, we eliminated
95% of our data during outlier detection. Because we were
comparing crypt subsections from the same patient, any vari-
ability from interpatient differences would not be encountered.
Therefore, it is highly unlikely that there were many false posi-
tives left over in the gene list. While admittedly it is very likely
that we eliminated a number of false negatives from further
consideration, our goal was to identify SC-specific profiles, and it
was therefore more important for us to identify true potential
expression markers for each of the crypt subregions.
Rather than using an unsupervised visual exploratory
approach, such as clustering, to determine interesting groups
of genes, we simply looked for data that were consistent
across all four replicates per sample and used the resulting
list of upregulated genes to generate a list of potential
markers for each crypt region.
Once we generated gene lists for each subregion, we used
K-means clustering and hierarchical clustering to validate
the lists. While we did not identify a functional pathway
through K-means clustering, the similarity of the results
from the two data sets (1 and 2) suggests that if we had not
eliminated so much data, we might have found a potential
pathway through this method. Likewise, the hierarchical
clustering results show that there is clearly a unique gene
expression signature in the bottom of the crypt compared
with the top and middle. Indeed, we found that several
of the upregulated genes in the crypt bottom map to the
phosphatidylinositol-3-kinase (PI3K) pathway (discussed
below).
FIG. 6. Co-staining images for HOXD10 and HOXA4 with SC markers (CD166 and ALDH1) in normal colonic crypts. (A, B)
Co-staining for HOXD10, HOXA4, and CD166. Blue indicates nuclear staining with Hoechst dye; green indicates CD166
expression; red indicates HOXD10 and HOXA4 expression. CD166-positive cells co-stained with HOXD10 and HOXA4 at the
bottom of the normal colonic crypt. Scale bar = 20 mm. (C, D) Co-staining for HOXD10, HOXA4, and ALDH1 in normal
colonic crypts. Blue indicates nuclear staining with Hoechst dye; green indicates ALDH1 expression; red indicates HOXD10
and HOXA4 expression. ALDH1-positive cells co-stained with HOXD10 and HOXA4 at the bottom of the normal colonic
crypt. Scale bar= 10mm. Color images available online at www.liebertpub.com/scd
(Continued/)
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Following cluster analysis, we performed gene ontology
and annotation analysis to determine, through an evaluation
of their known functions, whether our list of genes corre-
sponded to SC-specific functions reported in the literature.
Gene ontology on these lists showed that the upregulated
genes from each of the gene lists play a role in growth and
development.
To validate our findings that the expression results were
truly representative of genes expressed in the SC niche, we
analyzed, using real-time PCR, two groups of genes. Group 1
included HOXD10, HOXA4, and STAMP1. Group 2 included
five known SC markers as positive controls (LGR5, CD166,
CD133, DCLK1, and ALDH1). The analysis was done on
bottom crypt subsections compared to middle crypt sub-
sections. Results indicated that our microarray analysis
method accurately identified genes whose expression was
increased (Fig. 3) in the bottom relative to the middle crypt
subsections.
Nature of the genes that showed differential
expression: HOX, STAMP1, and PI3 kinase
Two HOX genes were identified in our microarray anal-
ysis as being upregulated in the crypt bottom. One was
HOXD10 and the other HOXA4. Both these genes were
validated by real-time analysis, and thus these HOX
genes are putative markers for SC at the crypt bottom.
Immunostaining confirmed the presence of HOXA4 and
FIG. 6. (Continued).
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FIG. 7. Expression of HOXD10 and HOXA4 in CRCs. (A) Overexpression of HOXD10 and HOXA4 in CRCs. Real-time PCR
was done using expression of the indicated genes in colon samples (carcinomas and purified, normal colonic epithelium);
n = 6 for HOXA4; n= 5 for HOXD10). Bars show the mean – SEM. (B) Co-staining for HOXA4 and HOXD10 with SC markers
in CRCs. (a, b) Co-staining for HOXD10, HOXA4, and CD166 in CRCs. Blue represents nuclear staining with Hoechst dye;
green represents CD166 expression; red represents HOXD10 and HOXA4 expression. Increased co-staining is seen for
HOXD10, HOXA4, and the SC-marker CD166 in tumor tissues. Scale bar = 20 mm. (c, d) Images of co-staining of HOXD10,
HOXA4, and ALDH1 in CRC. Blue indicates nuclear staining with Hoechst dye; green indicates ALDH1 expression; red
indicates HOXD10 and HOXA4 expression. Increased co-staining is seen for HOXD10, HOXA4, and ALDH1 in tumor tissues.
*P < 0.05; **P < 0.005. Scale bar = 20 mm. CRC, colon carcinoma. Color images available online at www.liebertpub.com/scd
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HOXD10 in the SC-enriched region at the bottom of the
crypt. This is thus the first report showing that there is a
unique gene expression pattern, which includes HOXA4 and
HOXD10, in the SC niche at the crypt bottom. Our im-
munostaining data show that the expression of these genes is
substantially increased in CRCs.
Both HOX genes have been reported to have an important
role in embryonic development and in regulation of SCs.
Disruption of HOXD10 expression causes severe hindlimb
locomotor defects [6,7]. HOXA4 plays a role in SC regulation
[8] and is important in proper development of the enteric gut
[9]. Expression of the HOXA gene family is upregulated in
the proliferative zone at the base of the crypt [10]. Aberrant
expression of a few HOX genes has been previously reported
in CRCs and CRC cell lines. For example, the HOX genes,
HOX A9, HOX D11, and HOX B7 have all been found to be
aberrantly expressed in primary CRCs [11]. Other studies
showed upregulation of HOXB6, HOXB8, HOXC8, and
HOXC9 in CRCs [12]. Given that HOX genes are important
in embryonic development and organogenesis, a balance
between the relative expression of different HOX genes has
been considered to be essential to the maintenance of tissue-
specific SCs [13].
There is little known about STAMP1, which we found to
be the most upregulated gene at the crypt bottom. It has been
implicated as a marker for the progression of prostate cancer
and co-localizes with EEA1 in the Golgi apparatus [14].
STAMP1 expression is exclusively expressed in epithelial
cells of the prostate and is increased in prostate cancer
compared with normal prostate [15]. Given that STAMP1 is a
cell surface antigen (with a six transmembrane domain), it
may be useful for isolating colonic SC or maybe even serve
as a therapeutic target.
Among the set of genes that we found were upregulated
in the crypt bottom relative to the other two subsections were
genes that mapped to the PI3K pathway. The PI3K pathway
has been implicated in the cell’s decision between survival,
proliferation, and differentiation [16]. PI3K is a key signaling
molecule in this pathway. PI3K is frequently mutated in
human cancers, resulting in unregulated activation of PI3K
signaling [17]. Interestingly, one third of CRCs showed so-
matic mutations in PI3K [18].
Pilot analysis of FAP crypts
Our pilot study was designed to compare expression of
putative crypt SC genes in whole normal versus whole APC-
mutant (FAP) crypts. This involved a survey of a subset of
genes (n = 47) from our main study, which established a
signature for the crypt bottom of healthy controls. The data
showing that 18 of these genes are overexpressed in colonic
crypts from FAP patients suggest that germline APC muta-
tions can cause an increase in expression of those genes that
are selectively expressed in the normal SC niche. This finding
is consonant with our previous studies that showed that SC
overpopulation occurs in FAP colon: (1) our mathematical
modeling studies [19,20] of the known proliferative change
[21–23] in FAP crypts implicating SC overproduction in CRC
initiation, (2) our immunohistochemical study [24] on crypts
from FAP patients showing that APC mutations cause ex-
pansion of the crypt base cell population, (3) our proteomic
(2D PAGE) analyses [25,26] showing that germline APC
mutations alter protein expression in colonic crypts and fi-
broblasts from FAP patients. Moreover, we did a study [27]
that used SC markers (ALDH1, CD44, and CD133) and
quantitative immunohistochemical mapping to track SC
population size in colonic crypts during colon tumorigenesis.
This latter study showed that the number of SCs increased
(by 2.5-fold) in normal-appearing FAP crypts, and increased
even further (by 5.2-fold) in adenomatous crypts from FAP
patients.
Expression of HOX genes in CRCs
Because we saw increased expression of HOXA4 and
HOXD10 genes in the SC-enriched population at the crypt
bottom, we wanted to determine whether these genes are
actually expressed in colonic SC. CD166 and ALDH1 are
known to be specific markers commonly used to identify co-
lon SC [27–30]. Consequently, we determined whether
HOXA4 and HOXD10 are co-expressed in cells that stain for
the SC markers CD166 and ALDH1. Indeed, our results
showed that HOXA4 and HOXD10 genes are co-expressed
with CD166 and ALDH1 in cells within the SC niche of the
normal colonic crypt. Co-staining was considerably increased
in CRCs. Thus, our co-staining results also validate our data
on gene expression from microarray analysis. This leads us to
hypothesize that HOXA4 and HOXD10 genes play a role in
maintenance of SC populations in normal colon, and that
upregulation of these genes contributes to the crypt SC
overpopulation [1,19,20,24,27] that drives CRC development.
HOX genes in development and SC self-renewal
Our microarray analysis showed 18 genes were uniquely
expressed at the base of the crypt (a SC-enriched region) and
these genes were classified as being involved in develop-
ment and cell growth or maintenance. We found that
HOXA4 and HOXD10 genes are expressed in colon SCs. This
made us hypothesize as follows: (1) HOX genes are involved
in colon SC self-renewal pathways and (2) their aberrant
expression contributes to the SC overpopulation that drives
CRC development.
Conclusions
Using an innovative ‘‘comparative’’ gene expression pro-
filing approach to identify genes selectively expressed in the
stem cell-enriched crypt region (bottom) compared to those
genes expressed in crypt regions containing mostly prolif-
erating cells (middle) or terminally differentiated cells (top),
we discovered a unique signature for the crypt bottom that
contains many genes that have functions consistent with
known biologic roles involving SCs. Indeed, two of the genes
are HOXA4 and HOXD10, which are known to be important
in development. Their expression in the crypt bottom sug-
gests that HOX genes play a role in maintenance of SC
populations in the SC niche of the normal crypt. Over-
expression of HOXA4 and HOXD10 in colon tumors suggests
that HOX genes contribute to crypt SC overpopulation
[1,19,20,24,27], which drives development of CRC in humans.
Taken together, our findings indicate that ‘‘comparative’’
expression profiling of different cell subpopulations within
any given human tissue is a valuable tool for identifying
genes that are expressed in normal SCs and determining
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which will become overexpressed during tumorigenesis. In
this way, genes might be identified that contribute to SC
overpopulation and drive development of cancers in humans.
For example, this approach might help determine the mech-
anisms that lead to increased symmetric division of SCs,
which is the mechanism thought to underlie development of
cancer SC overpopulation [31]. Identifying such mechanisms
may also suggest more effective molecular targets for new
approaches to cancer treatment and chemoprevention.
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